How Longlead Capital defied the covid plunge

I love investing in companies that boast strong financial positions. These three cheap ASX shares could fit the bill and screen cheaply according to...

Stocks

Overpriced ASX company too successful in wrong channel

Booming online sales cannibalising more profitable in-store sales.

Stocks

More promising signs for ASX listed software player

This moated small-cap looks undervalued versus our forecasts. Let alone management’s more ambitious growth targets.

Stocks

Overvalued ASX pharma play hits FDA speedbump

We think a delay rather than an outright rejection for this company’s product is the likelier outcome, but the shares still look expensive.